SCHEMBL25938563

SCHEMBL25938563

CC(C)Cc1nccc2c1nc(Cn1cccc(NC=O)c1=O)n2C(=O)OC(C)(C)C

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25938521 0.87 MAP4K1 (0.49) MAP4K1
SCHEMBL21703143 0.87 MAP4K1 (0.58) MAP4K1
SCHEMBL25940429 0.80 MAP4K1 (0.46) MAP4K1
SCHEMBL23452731 0.78 MAP4K1 (1.00) MAP4K1
SCHEMBL31450665 0.78 MAP4K1 (1.00) MAP4K1
SCHEMBL25941682 0.78 MAP4K1 (0.46) MAP4K1
SCHEMBL25938622 0.76 MAP4K1 (0.49) MAP4K1
SCHEMBL21703146 0.73 MAP4K1 (0.47) MAP4K1
SCHEMBL25944837 0.73 MAP4K1 (0.63) MAP4K1
SCHEMBL21685654 0.73 MAP4K1 (0.45) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed